April 24, 2020
Life Science Institute, a Mitsubishi Chemical Group company, said on April 23 that its multi-lineage differentiating stress enduring (Muse) cell product CL2020 demonstrated favorable safety and tolerability profiles in clinical trials for acute myocardial infarction and ischemic stroke. In the...read more